测试版
试验雷达 AI
临床试验 NCT07501793 (TAK-003) 针对All Individuals Who Have Received at Least One Dose of TAK-003 (Qdenga) Dengue Vaccine目前进行中（不再招募）。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情，或在此提出任何问题。
一个试验符合筛选条件
卡片视图
返回搜索

Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam 800,000 疫苗

进行中（不再招募）
临床试验详情主要以英语提供。然而，试验雷达 AI可以提供帮助！只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT07501793 (TAK-003)是一项针对All Individuals Who Have Received at Least One Dose of TAK-003 (Qdenga) Dengue Vaccine的观察研究试验，目前试验状态为进行中（不再招募）。试验始于2026年3月16日，计划招募800,000名患者。该研究由Tam Anh Research Institute主导，预计于2026年4月30日完成。试验数据来源于ClinicalTrials.gov，最后更新时间为2026年3月30日。
简要概括
The study aims to retrospectively describe the demographic characteristics, comorbidity profiles, vaccination history and vaccination patterns of all individuals who have received at least one dose of TAK-003 (Qdenga) dengue vaccine at all VNVC centers between September 26, 2024 and September 30, 2025. The study will utilize existing data from the VNVC immunization database. No new data collection or direct participa...显示更多
详细描述
This is a retrospective, observational, multicenter study using existing vaccination records from the Vietnam Vaccine Joint Stock Company (VNVC) immunization database. The study will analyze data from all individuals who received at least one dose of the TAK-003 (Qdenga) dengue vaccine between September 26, 2024 and September 30, 2025. No new data collection or participant contact will be performed.

The study will b...

显示更多
官方标题

Demographic Profile of TAK-003 (Qdenga) Dengue Vaccine Recipients During the First Year of the Vaccination Period at VNVC Vaccination Centers in Vietnam

疾病
All Individuals Who Have Received at Least One Dose of TAK-003 (Qdenga) Dengue Vaccine
其他研究标识符
  • TAK-003
  • TA-0013
NCT编号
NCT07501793
实际开始日期
2026-03-16
最近更新发布
2026-03-30
预计完成日期
2026-04-30
计划入组人数
800,000
研究类型
观察研究
试验状态
进行中（不再招募）
关键词
TAK-003
QDENGA
Dengue Vaccine
Vietnam
Demographics
Retrospective Study
VNVC
主要终点
结果指标度量标准描述时间框架
Demographic and clinical characteristics of individuals who received at least one dose of the TAK-003 dengue vaccine at VNVC vaccination centers in Vietnam
To describe the demographic and clinical characteristics (age, sex, ethnicity, geographic distribution, underlying medical conditions, concomitant vaccination and vaccination history) of individuals who received at least one dose of the TAK-003 dengue vaccine at VNVC vaccination centers in Vietnam during the study period
Day 0 after recruitment
次要终点
结果指标度量标准描述时间框架
Vaccination coverage of TAK-003 first and second doses
To estimate the vaccine coverage of TAK-003 first dose and second dose in the study population and in Vietnam population
Day 0 after recruitment
Associations between demographics, clinical characteristics, and vaccination patterns
To explore potential associations between demographic and clinical characteristics and TAK-003 vaccination patterns
Day 0 after recruitment
参与助手
资格标准

适龄参与研究
儿童, 成人, 老年人
最低年龄要求
4 Years
适龄性别
全部
接受健康志愿者
是
  • All individuals who were vaccinated with at least one dose of TAK-003 at all VNVC vaccination centers in Vietnam from 26/09/2024 to 30/09/2025

  • Cases in which TAK-003 vaccination occurred outside the defined study period (from September 26, 2024, to September 30, 2025).
  • Records that are duplicates, missing or contain inconsistent information on key demographic or clinical characteristics (age, sex, TAK-003 dose \[first or second\]) as such data are essential for analysis
Tam Anh Research Institute logoTam Anh Research Institute
没有联系数据。
1 位于 1 个国家/地区的研究中心

Ho Chi Minh

Vietnam Vaccine Joint Stock Company, Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam